BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 24406159)

  • 21. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients.
    Yamashita H; Deng J; Liang H; Seto Y
    Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer.
    Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS
    Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
    Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
    Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer.
    Saze Z; Terashima M; Kogure M; Ohsuka F; Suzuki H; Gotoh M
    Dig Surg; 2012; 29(2):115-23. PubMed ID: 22456124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis and surgical treatment of gastric cancer invading adjacent organs.
    Zhang M; Zhang H; Ma Y; Zhu G; Xue Y
    ANZ J Surg; 2010; 80(7-8):510-4. PubMed ID: 20795964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
    Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
    Guo C; Wang W; Shi Q; Chen P; Zhou C
    Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early gastric cancer with lymph node metastasis.
    Kosuke N; Oguma H; Yamamoto M
    Ann Surg; 2011 Apr; 253(4):840-1; author reply 841. PubMed ID: 21475033
    [No Abstract]   [Full Text] [Related]  

  • 35. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features and outcome of surgical treatment of 149 patients with early (pT1) gastric cancer.
    Skoropad V; Berdov B; Zagrebin V
    Onkologie; 2005 May; 28(5):247-52. PubMed ID: 15867480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3 expression in gastric cancer indicates a poor prognosis.
    Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
    J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
    Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
    Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer.
    Wang J; Yu JC; Kang WM; Wang WZ; Liu YQ; Gu P
    Ann Surg Oncol; 2012 May; 19(5):1529-34. PubMed ID: 22009269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.